60 Degrees Pharma Announces IRB Approval of Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis
Investigational Review Board (IRB) approval has been granted for the open-label study…
Investigational Review Board (IRB) approval has been granted for the open-label study…
Sign in to your account